001     910951
005     20240117202332.0
024 7 _ |a 10.1017/S0033291721002725
|2 doi
024 7 _ |a 0033-2917
|2 ISSN
024 7 _ |a 1469-8978
|2 ISSN
024 7 _ |a 2128/32643
|2 Handle
024 7 _ |a WOS:000785644900001
|2 WOS
037 _ _ |a FZJ-2022-04279
082 _ _ |a 610
100 1 _ |a Maier, Franziska
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction
260 _ _ |a [S.l.]
|c 2021
|b Proquest
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1705493653_18596
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundImpaired self-awareness of cognitive deficits (ISAcog) has rarely been investigated in Parkinson's disease (PD). ISAcog is associated with poorer long-term outcome in other diseases. This study examines ISAcog in PD with and without mild cognitive impairment (PD-MCI), compared to healthy controls, and its clinical-behavioral and neuroimaging correlates.MethodsWe examined 63 PD patients and 30 age- and education-matched healthy controls. Cognitive state was examined following the Movement Disorder Society Level II criteria. ISAcog was determined by subtracting z-scores (based on controls' scores) of objective tests and subjective questionnaires. Neural correlates were assessed by structural magnetic resonance imaging (MRI) and 2-[fluorine-18]fluoro-2-deoxy-d-glucose-positron emission tomography (FDG-PET) in 47 patients (43 with MRI) and 11 controls. We analyzed whole-brain glucose metabolism and cortical thickness in regions where FDG-uptake correlated with ISAcog.ResultsPD-MCI patients (N = 23) showed significantly more ISAcog than controls and patients without MCI (N = 40). When all patients who underwent FDG-PET were examined, metabolism in the bilateral superior medial frontal gyrus, anterior and midcingulate cortex negatively correlated with ISAcog (FWE-corrected p < 0.001). In PD-MCI, ISAcog was related to decreased metabolism in the right superior temporal lobe and insula (N = 13; FWE-corrected p = 0.023) as well as the midcingulate cortex (FWE-corrected p = 0.002). Cortical thickness was not associated with ISAcog in these regions. No significant correlations were found between ISAcog and glucose metabolism in controls and patients without MCI.ConclusionsSimilar to Alzheimer's disease, the cingulate cortex seems to be relevant in ISAcog in PD. In PD-MCI patients, ISAcog might result from a disrupted network that regulates awareness of cognition and error processes.KeywordsAnosognosiaimpaired self-awarenessmild cognitive impairmentmultimodal neuroimagingParkinson's disease
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Greuel, Andrea
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hoock, Marius
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kaur, Rajbir
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Tahmasian, Masoud
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Schwartz, Frank
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Csoti, Ilona
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Jessen, Frank
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Drzezga, Alexander
|0 P:(DE-Juel1)177611
|b 8
700 1 _ |a van Eimeren, Thilo
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Timmermann, Lars
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Eggers, Carsten
|0 P:(DE-HGF)0
|b 11
773 _ _ |a 10.1017/S0033291721002725
|g p. 1 - 10
|0 PERI:(DE-600)1470300-2
|p 1 - 10
|t Psychological medicine
|v 1
|y 2021
|x 0033-2917
856 4 _ |u https://juser.fz-juelich.de/record/910951/files/Impaired%20self-awareness.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:910951
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Department of Psychiatry and Psychotherapy, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany
|0 I:(DE-HGF)0
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany
|0 I:(DE-HGF)0
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Department of Neurology, Hospital of the Brothers of Mercy, Trier, Germany
|0 I:(DE-HGF)0
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Gertrudis Clinic, Parkinson-Center, Leun-Biskirchen, Germany
|0 I:(DE-HGF)0
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Department of Psychiatry and Psychotherapy, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany German Center for Neurodegenerative Disorders (DZNE), Bonn, Germany
|0 I:(DE-HGF)0
|b 7
|6 P:(DE-HGF)0
910 1 _ |a German Center for Neurodegenerative Disorders (DZNE), Bonn, Germany
|0 I:(DE-HGF)0
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a Department of Nuclear Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
|0 I:(DE-HGF)0
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-2), Research Center Jülich, Jülich, Germany
|0 I:(DE-HGF)0
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-2), Research Center Jülich, Jülich, Germany Department of Neurology, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich,Jülich, Germany
|0 I:(DE-HGF)0
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany
|0 I:(DE-HGF)0
|b 10
|6 P:(DE-HGF)0
910 1 _ |a : Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Giessen, Giessen and Marburg, Germany
|0 I:(DE-HGF)0
|b 11
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 1
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2021-02-04
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-02-04
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PSYCHOL MED : 2019
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-04
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-02-04
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b PSYCHOL MED : 2019
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-04
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-04
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 0
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21